HeiLongJiang ZBD Pharmaceutical Co., Ltd.SSE: 603567

(603567)"Heilongjiang ZBD Pharmaceutical Co., Ltd."Report for Q3 2026

Oct 31, 2026 · Issued by HeiLongJiang ZBD Pharmaceutical Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · Stock code 603567 · Oct 31, 2026 · 13 pages · Chinese

On 6ix: 6ix.com/news/603567heilongjiang-zbd-pharmaceutical-co-ltdreport-for-q3-2026

HeiLongJiang ZBD Pharmaceutical Co., Ltd. on 6ix

Earlier from HeiLongJiang ZBD Pharmaceutical

(603567)"Heilongjiang ZBD Pharmaceutical Co., Ltd."Announcement on Progress in Providing Guarantee for Wholly-owned SubsidiaryOct 29
(603567)"Heilongjiang ZBD Pharmaceutical Co., Ltd."Announcement on Departure of the Director and Board Secretary and Designation of the Chairman to Act as the Board SecretaryOct 29
(603567)"Heilongjiang ZBD Pharmaceutical Co., Ltd."Notice on Convening the 5th Extraordinary General Meeting in 2026Oct 28
(603567)"Heilongjiang ZBD Pharmaceutical Co., Ltd."Announcement on Termination of Certain Raised Funds Investment Projects and Continued Deposit of Remaining Raised Funds in Special Accounts for Raised FundsOct 28
(603567)"Heilongjiang ZBD Pharmaceutical Co., Ltd."Announcement on Resolutions of the 6th Meeting of the 6th Board of DirectorsOct 28

All HeiLongJiang ZBD Pharmaceutical news releases

Follow HeiLongJiang ZBD Pharmaceutical into a list and get an email when it puts out news.

Follow HeiLongJiang ZBD Pharmaceutical